Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- 3DG Jewellery Celebrates Its 23rd Anniversary in Dazzling StyleHONG KONG, Sept 18, 2026 - 3DG Holdings (International) Limited (“3DG Holdings” or the “Group”) (Stock Code: 2882) is pleased to celebrate the 23rd anniversary. To commemorate this milestone, the brand has invited renowned designer and illustrator Mr. Alex Gan, known for his delicate style and dreamlike brushwork, to create an exclusive anniversary-themed artwork. This crossover collaboration embodies the brand’s “Young at Heart” philosophy through jewellery. Drawing inspiration from 3DG Jewellery’s signature products, the artist has transformed classic design elements into imaginative illustrations. These include the Eight Treasures Compass from the “Classic Gold” collection, the four-leaf clover from the “Golden Allure GA” collection and the feather from the “Bling Bling Gold” collection, offering a new artistic interpretation of jewellery aesthetics. Taking centre stage in the celebration is the newly launched “Bling Bling Gold” Phalaenopsis Orchid Collection. The collection combines graceful, three-dimensional contours with the brand’s exclusive Bling Bling Gold craftsmanship and technology, allowing the gold surface to refract a spectrum of colours as the light shifts. Designed to complement both wedding occasions and everyday styling, the collection seamlessly combines romantic sophistication with modern versatility, allowing wearers to express their individuality with confidence and elegance. In addition, a range of exclusive co-branded merchandise, including gift boxes, tumblers and stylish scarves, will be launched during the campaign, offering customers an artistic experience that engages both sight and touch. A host of limited-time offers will also be rolled out, with selected jewellery pieces available at a special appreciation price of HK$2,388, as a token of gratitude for customers’ continued support. Cross-Industry Collaboration: Art-Inspired Jewellery, with Dreamlike Elements Woven into the Designs Renowned designer and illustrator Mr. Alex Gan drew his creative inspiration from a romantic starry sky, using gold and holographic silver as the dominant tones. Gold symbolises the precious metal, while holographic silver represents the dazzling brilliance of jewellery. The artwork adopts a swirling, encircling composition that evokes a sense of fluid movement. Shooting stars streak across the sky as graceful hummingbirds and fluttering butterflies act as guides, accompanied by soft velvet ribbons and exquisite jewellery. Together, these elements create a light and dynamic sense of moving towards something longed for. Gilded flowers burst into bloom while pristine feathers unfurl and dance across the sky, intertwining as they converge into a glittering vortex of swirling light, surrounded by delicate sparkles of starlight. The layered interplay of light and shadow creates a refined and dreamlike atmosphere, with the silhouette of a beautiful young woman appearing subtly amid the starlight. Each visual element echoes the others, giving concrete form to romantic imagery. Through symbols such as starlight, blossoms, wings, butterflies and birds, the artwork conveys the vibrant and ever-renewing inner vitality of love, resulting in an artistic visual expression that combines aesthetic beauty with emotional meaning. This cross-industry collaboration embodies the brand’s “Young at Heart” philosophy, demonstrating how jewellery can transcend the boundaries of age and time, empowering every woman to discover her own moment to shine. Inspired by 3DG Jewellery’s signatureCollections, Mr. Gan has woven the brand’s classic designs into the artwork. The curves of the butterfly’s outstretched wings echo the silhouette of the “Bling Bling Gold” butterfly designs; the lightness of the feathers mirrors the ethereal elegance of the “Bling Bling Gold” feather design; and the four-leaf clover and Eight Treasures Compass motifs directly reference the classic designs of the “Golden Allure GA” and “Classic Gold” collections. Through this creative dialogue between art and jewellery, each discipline inspires and elevates the other, bringing timeless designs to life through a fresh and imaginative perspective. “Classic Gold” Collection – Eight Treasures Compass Design Gold Pendant with Ruby and Diamonds Design, craftsmanship and features The Eight Treasures Compass brings together eight auspicious symbols, representing the fulfilment of blessings and wisdom, and enduring good fortune. The vajra represents firm and incisive wisdom that dispels ignorance and overcomes obstacles. Crafted using traditional goldsmithing techniques and set with rubies and diamonds, the design features a rotating vajra at its centre, allowing auspiciousness and everlasting fulfilment to flow through everyday life. “Golden Allure GA” Collection – Four-Leaf Clover Design Gold Pendant with Diamonds Design, craftsmanship and features A diamond-accented four-leaf clover, with luck woven into its leaf veins. Its delicate veins interlace and spread like the effortless beauty of nature, outlining a vibrant sense of vitality. Studded with diamonds, the design quietly blends the pure beauty of nature with artisanal craftsmanship. Every 5G gold vein carries the classic blessings of the four-leaf clover, with happiness hidden within its leaf patterns and vitality captured in its design. The piece not only echoes the harmonious coexistence of nature and art, but also ensures the wearer is constantly surrounded by good wishes. “Bling Bling Gold” Collection – Feather Design Gold Pendant Design, craftsmanship and features A single feather of breathtaking grace, born bathed in light. This 5G gold feather is the embodiment of lightness, symbolising the guidance of light and the favour of good fortune, like an invisible pair of hands silently bestowing protection and blessings. Adorned in colour, the feather takes on an even deeper meaning, giving every aspiration for growth a vibrant and warm undertone. Featured Collection: “Bling Bling Gold” Phalaenopsis Orchid Collection Radiates Timeless Brilliance As the flagship highlight of the 23rd anniversary celebration, the “Bling Bling Gold” Phalaenopsis Orchid Collection makes a striking debut. The Collection combines phalaenopsis orchids with graceful butterflies. Through the use of 5G Bling Bling Gold craftsmanship and Italian filigree techniques, the surface achieves a dazzling lustre with distinct layers, radiating timeless brilliance. Available in large, medium and small versions, the thematic designs combine versatile fashion appeal with the symbolism of beauty and happiness, breaking free from the conventions of traditional bridal jewellery to present a modern bridal style for a new generation. From weddings to everyday attire, the pieces can be effortlessly styled to enable the wearer to shine at every moment. “Bling Bling Gold” Collection – Phalaenopsis Orchid Design Design, craftsmanship and features Gradated phalaenopsis orchids and graceful butterflies create a rhythmic sense of dynamic beauty, capturing a vivid moment in a spring garden. 5G Bling Bling Gold and Italian handcrafted filigree outline the petals, with fine gold wires shaped precisely to follow the contours of each flower, recreating the beauty of the layered, unfurling blossoms. The shimmering gold surface complements the openwork filigree, perfectly blending bridal festivity with the natural grace of flowers. Gold Necklace Gold Earrings Gold Ring Gold Bangle More from the “Bling Bling Gold” Butterfly Collection Gold Pendant Design, craftsmanship and features Inspired by the butterfly as a symbol of love, this piece conveys a heartfelt wish for enduring devotion between lovers. Crafted with 5G gold as its foundation, the butterfly silhouette is precisely cast and enhanced with a combination of CNC sparkle-cut gold and Bling Bling Gold techniques, complemented by hand-wound filigree detailing to create three-dimensional layering and dazzling lustre. Perfect for both daily wear or as a festive gift. Design, craftsmanship and features A versatile range of affordable-luxury designs inspired by the beauty of a butterfly’s metamorphosis, featuring lightweight butterfly silhouettes crafted in 5G gold. The deluxe necklace features butterflies in graduated sizes extending from both sides of the neckline toward the centre. Small butterflies flutter delicately while larger ones unfold their wings in full splendour, as if a flock of butterflies were following a trail of light and shadow, symbolising the beauty and hope found in life’s transformations. Design, craftsmanship and features Crafted using gold wire-wrapping techniques, the fluttering butterfly wings shimmer with iridescent hues, capturing the breathtaking moment a butterfly emerges from its cocoon and takes flight, accompanying the wearer through every wonderful moment. 23rd Anniversary Exclusive Privileges and Special Offers To celebrate its 23rd anniversary, 3DG Jewellery is presenting a series of exclusive privileges starting from 19 September 2026, adding extra joy and excitement to customers’ jewellery shopping experience: Offer 1: Celebrating with Woven Flowers Customers who visit any 3DG Jewellery store and scan the in-store QR code will receive one complimentary handmade woven flower, sharing blessings through this little gift. Click here to play the online game. Upon completion, participants will receive a complimentary redemption coupon for a multi-functional luggage tag with mirror, as well as a 25% off diamond purchase coupon. Offer 2: Anniversary Special Selected jewellery pieces are available at a special appreciation price of HK$2,388, as a heartfelt token of gratitude for customers’ support. Offer 3: Anniversary Gifts Receive a complimentary “3DG Jewellery Gift Box” with any purchase; a “3DG Jewellery Fashion Scarf” with a purchase of HK$5,300 or above; and a “3DG Jewellery Tumbler” with a purchase of HK$8,300 or above. Gifts are available in limited quantities, while stocks last. Offer 4: Exclusive Member Benefits Members purchasing products from the “Bling Bling Gold” collection will receive double bonus points. Members can also redeem designated gifts using 30% fewer points, allowing them to enjoy exclusive privileges. The above offers are subject to the relevant terms and conditions. For details, please refer to in-store promotional materials or visit the official website. For more high-resolution photos, please click here to download About Mr. Alex Gan, Designer and Illustrator Illustrator Mr. Alex Gan graduated from the Academy of Arts & Design at Tsinghua University, China. He has long been engaged in the study and practice of illustration inspired by the artistic language of copperplate engraving. Skilled at controlling the rhythm of simple lines and their complex interweaving, he creates richly detailed and delicate visual effects, and uses this approach to present intricate compositions imbued with a vintage flair and strong narrative. He is also adept at exploring and applying a wide range of cultural symbols, giving his works a sense of sophistication and refinement. Mr. Gan has provided illustration services for numerous prestigious brands, and his work has won multiple international awards, including the Silver A’ Design Award (Italy), Pentawards Silver, MUSE Design Awards Platinum (USA) and the iF Design Award (Germany). About 3DG Holdings (International) Limited (Stock Code: 2882) 3DG Jewellery is a distinguished jewellery brand from Chinese Mainland and a member of the Luk Fook Group. The brand is mainly engaged in design, product development, and retailing of gem-set jewellery products under the “3DG Jewellery” name and gold and platinum jewellery, it also provides customized corporate gift services. Since 2003, 3DG Jewellery has established a retail network in Chinese Mainland, Hong Kong S.A.R., Thailand and Australia, with nearly 300 shops, its brand image is deeply recognized and affirmed. Embracing the brand philosophy of “Young at Heart,” 3DG Jewellery crafts stylish and distinctive pieces. With its unique product charm and “3DG Prestige Service”, the brand has won the recognition of consumers and celebrities, while also receiving widespread praise throughout its development. For more information, please visit the official website of 3DG Jewellery at: https://www.3dg-group.hk/
- Duquesne UniversityDuquesne Continues Momentum with Inauguration of President David DauseyPittsburgh native and nationally recognized epidemiologist outlines vision as University approaches 150th anniversary PITTSBURGH , Sept. 17, 2026 -- With record interest from prospective students, expanding academic programs and its 150th anniversary on the horizon, Duquesne...
- Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia's Commitment to Lead the Future of BiotechnologyRIYADH, KSA, Sept 18, 2026 - The Riyadh Global Medical Biotechnology Summit closed today as a major success in its fourth edition and a clear statement of the scale of Saudi Arabia's ambition in biotechnology. Over three days, more than 15,000 visitors from more than 57 countries and more than 200 speakers across more than 70 sessions saw that ambition turned into more than 40 agreements, initiatives, and announcements with a combined declared value of more than SAR 5 billion (USD 1.33 billion), up from more than USD 100 million in deal value generated at the 2024 edition. Partners came from Spain, China, Japan, Germany, the United States, South Korea, Denmark, and Malaysia to join the Kingdom's leading universities, research centers, and manufacturers at the Sofitel Riyadh Hotel and Convention Centre, where more than 120 sponsors and exhibitors filled 6,000 square meters of event space and more than 180 strategic meetings took place. More than 40 agreements and announcements, initiatives, and announcements worth more than SAR 5 billion (USD 1.33 billion) delivered on every pillar of the Summit, from national strategy and regulation to investment, research readiness, and talent, with participants from more than 57 countries in Riyadh. The Summit opened on 14 September under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, and was inaugurated by His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of National Guard. His Excellency Prof. Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC) Chairman of RGMBS, addressed the opening ceremony, describing the Summit as a platform for advancing the National Biotechnology Strategy launched by His Royal Highness the Crown Prince in January 2024, at a time of rapid and far-reaching discovery in the field. Her Royal Highness Princess Dr. Maha bint Mishari bin Abdulaziz Al Saud, Chief Executive Officer of the FII Institute, addressed the opening ceremony. Her Royal Highness highlighted the role of capital, ideas, and long-term alliances in turning scientific breakthroughs into lasting impact on humanity. She placed the human purpose of the field at the center of the Summit's work: extending not only the length of life but its quality, so that patients gain more time, and better time, with the people they love. FOUR PILLARS, ONE NATIONAL MISSION RGMBS 2026 was built on four pillars under the theme Building the Foundations of Biotechnology Excellence, with each pillar explored through scientific, panel, and executive sessions. Governmental strategies and regulatory support. KAIMRC and the Ministry of Investment launched BioSync. The one stop shop for every biotech investor, consolidating the Kingdom's entire life sciences ecosystem into a single, authoritative platform. Regulators and scientists shared the stage throughout the program, culminating in a Day Three panel on regulation as an enabling scientific tool. Investment and funding. Vaccine Industrial Company confirmed that its human vaccine manufacturing facility, a SAR 500 million investment across 42,000 square meters, is 85 percent complete and is planned to localize up to 80 percent of the Kingdom's essential vaccine needs. Sanabil Studio by Redesign Health signed with Telepath by Tahlili on AI and digital pathology, with a potential investment of USD 3 million, and the Life Sciences Innovation Forum drew applications from more than 100 companies, nominated more than 25 for investment, and engaged five investment funds willing to invest with a combined value of more than USD 120 million. Research and development readiness. King Abdullah International Medical Research Center (KAIMRC) and Thermo Fisher Scientific announced a Center of Excellence for Genomics, Proteomics, and Biobanking. The University Hospitals Program at the Council of Universities' Affairs signed with Novo Nordisk to build clinical trial capability, including earlier phase trials. KAIMRC also agreed research collaborations with Olink in proteomics, Tiziana Life Sciences in immunomodulation and neuroimmunology, and Japan's Chiyoda Corporation in plant-based peptide production for cancer treatment. King Saud University and BioMe of South Korea signed to establish a microbiome joint venture, the University of Hafr Al Batin partnered with BGI Group, and Najran University launched the Najran Genomic Biobank Initiative. Building capabilities. KAIMRC signed with Rutgers University on a summer school, master's programs, and research in artificial intelligence, and with LeapUp on training and capacity building. Princess Nourah bint Abdulrahman University and Cellenkos launched a program to develop Saudi female talent in cell and gene therapy and biomanufacturing, and SVAX and Batterjee Medical College agreed accredited biomanufacturing training with up to 350 seats per cycle. King Saud University launched four national initiatives, including an annual Saudi International Biotechnology Conference and the KSU BioHack hackathon. THREE DAYS ON THE MAIN STAGE Day One: The program opened with the National Biotechnology Strategy and a session on global partnership with Dr. Steve Yang of WuXi AppTec, Mr. Alec Reynolds of Flagship Pioneering, and Prof. Ahmed Alaskar of KAIMRC, before turning to AI in biotechnology and multi-omics, including Prof. Jin-Soo Kim of KAIST on mitochondrial DNA editing beyond CRISPR. Day Two: Investment, immunology, and bioengineering took the stage, with Mr. Kasim Kutay of Novo Holdings on investing in AI, Prof. Keith T. Flaherty, President of the American Association for Cancer Research, on cancer immunology, Astronaut Rayyanah Barnawi on the human immune system in space, and Dr. Matthew H. Porteus of Stanford University on CRISPR-engineered cell-based drugs. Day Three: The final day focused on the biotechnology workforce and regulation, a closing keynote from Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, ahead of the closing ceremony. "RGMBS 2026 has shown the world what Saudi Arabia means when it says biotechnology is a national mission. We named this edition for foundations, and over three days those foundations were laid in full view: a vaccine plant nearing completion, a genomics center with Thermo Fisher, clinical trials with Novo Nordisk, and training for a new generation of Saudi scientists, each with a named partner and a defined scope. "Under the direction of our leadership and the National Biotechnology Strategy, the Kingdom is committed to leading this field for decades to come. We will measure that leadership by one standard above all: the difference it makes to the lives of patients and their families." H.E Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of KSAU-HS and KAIMRC Chairman of RGMBS . RGMBS 2026 was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC), with the Ministry of Investment, Invest Saudi, and the FII Institute serving as strategic partners. The commitments made in Riyadh advance the National Biotechnology Strategy, which targets a USD 34.6 billion contribution to non-oil GDP from biotechnology by 2040, and confirm the Kingdom's place at the forefront of global biotechnology in the years ahead. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: [email protected] Telephone: +966 559 810 777
- RGMBS 2026 Life Sciences Innovation Forum Draws More Than USD 120 Million in Investor Interest as 23 Global Biotech Innovators Pitch in RiyadhRIYADH, KSA, Sept 18, 2026 - The Life Sciences Innovation Forum (LSIF), the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), brought 23 biotechnology companies from eight countries to Riyadh to pitch to investors, judges, and leaders of the Kingdom's life sciences ecosystem. Companies from eight countries pitched to investors across five scientific heats, with Saudi Arabia the second-largest market represented. Dr Abdulaziz Alrifi, Director Of Partnerships, KAIMRC, stated, "We were proud to welcome leading investment firms that expressed their willingness to invest more than $USD 120 milliond in promising biotech opportunities emerging from LSIF 2026. The journey culminated with the announcement of the LSIF 2026 Grand Winner: Bilix from South Korea." On winning, a representative of Bilix enthused, "Winning LSIF 2026 is a great honor, however the real win is scaling our startup with the Kingdom's research ecosystem" Where RGMBS 2026 set out the scale of Saudi Arabia's biotechnology ambition, LSIF put that ambition in front of the founders and investors who will shape the sector's next decade. The United States led the cohort with eight companies, with Saudi Arabia second at four, followed by South Korea, the United Kingdom, Australia, France, Germany, and Switzerland. Several international companies presented pathways to localization, research, or clinical development in the Kingdom. FIVE HEATS, ONE FRONTIER Companies competed across five heats, each at the leading edge of life sciences innovation. AI and Bio Data. Amprologix of the United Kingdom presented AI-assisted discovery of narrow-spectrum peptide antibiotics targeting drug-resistant pathogens. Pneumatica Bio of Australia combines mechanistic modelling, machine learning, and automated cell experiments to better predict human therapeutic response, while Saudi company LinusBio MENA presented precision exposomics built on hair-based biomarker profiling. Vaccine Development and Biomanufacturing. Biotech Innovations Company of Saudi Arabia presented a recombinant-protein MERS-CoV vaccine program focused on regional biosecurity and local manufacturing. OctoCells of France presented an animal-free 3D bioscaffold platform designed to reduce the water, infrastructure, and manufacturing burden of producing biologics and cell therapies, and Cevza Therapeutics of Australia an RNA therapy platform with planned research and development localization in the Kingdom. Cellular Therapy and Gene Editing. CellKure of the United States highlighted Phase 1 results for its multi-antigen T-cell therapy in acute myeloid leukemia. MVRIX of South Korea presented an in vivo CAR-T approach using targeted mRNA delivery, and Saudi company Medixcel a platform to bring cell and gene therapy capabilities, partnerships, and manufacturing into the Kingdom. Bioengineering and Synthetic Biology. NanoZymeX of Switzerland presented a lipid nanoparticle platform to improve enzyme replacement therapy for lysosomal storage diseases, beginning with Pompe disease. AUREXO Therapeutics of the United States presented engineered bacterial vesicles for precision oncology, and Ingenskin Therapeutics of France an autologous skin substitute for chronic wounds, burns, and trauma. Diagnostics and Drug Discovery. SiNON Nano Sciences of the United States presented a carbon nanoparticle platform designed to cross the blood-brain barrier. Spirea of the United Kingdom presented a dual-payload antibody-drug conjugate platform to address cancer drug resistance, and Accanito Therapeutics of the United States a clinical-stage oncology platform with a proposal for technology transfer and local manufacturing in Saudi Arabia. Questions from judges and the audience concentrated on turning science into treatments: regulatory routes, clinical evidence, manufacturing scale-up, localization economics, and intellectual property. LSIF 2026 was sponsored by Chiyoda Corporation. Alongside Grand Winner Bilix, four category awards were presented: the Most Scalable Biotech Startup Award to CellKure, the Outstanding Founding Team Award to Quantabia, the Breakthrough Science Award to Swaza, and the Innovation Excellence Award to Agemica. LSIF 2026 took place as part of RGMBS 2026, held from 14 to 16 September in Riyadh. The Summit was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment, Invest Saudi, and the Saudi Data & AI Authority (SDAIA) serving as key strategic partners. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: [email protected] Telephone: +966 559 810 777
- Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia's Commitment to Lead the Future of BiotechnologyRIYADH, KSA, Sept 18, 2026 - The Riyadh Global Medical Biotechnology Summit closed today as a major success in its fourth edition and a clear statement of the scale of Saudi Arabia's ambition in biotechnology. Over three days, more than 15,000 visitors from more than 57 countries and more than 200 speakers across more than 70 sessions saw that ambition turned into more than 40 agreements, initiatives, and announcements with a combined declared value of more than SAR 5 billion (USD 1.33 billion), up from more than USD 100 million in deal value generated at the 2024 edition. Partners came from Spain, China, Japan, Germany, the United States, South Korea, Denmark, and Malaysia to join the Kingdom's leading universities, research centers, and manufacturers at the Sofitel Riyadh Hotel and Convention Centre, where more than 120 sponsors and exhibitors filled 6,000 square meters of event space and more than 180 strategic meetings took place. More than 40 agreements and announcements, initiatives, and announcements worth more than SAR 5 billion (USD 1.33 billion) delivered on every pillar of the Summit, from national strategy and regulation to investment, research readiness, and talent, with participants from more than 57 countries in Riyadh. The Summit opened on 14 September under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, and was inaugurated by His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of National Guard. His Excellency Prof. Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC) Chairman of RGMBS, addressed the opening ceremony, describing the Summit as a platform for advancing the National Biotechnology Strategy launched by His Royal Highness the Crown Prince in January 2024, at a time of rapid and far-reaching discovery in the field. Her Royal Highness Princess Dr. Maha bint Mishari bin Abdulaziz Al Saud, Chief Executive Officer of the FII Institute, addressed the opening ceremony. Her Royal Highness highlighted the role of capital, ideas, and long-term alliances in turning scientific breakthroughs into lasting impact on humanity. She placed the human purpose of the field at the center of the Summit's work: extending not only the length of life but its quality, so that patients gain more time, and better time, with the people they love. FOUR PILLARS, ONE NATIONAL MISSION RGMBS 2026 was built on four pillars under the theme Building the Foundations of Biotechnology Excellence, with each pillar explored through scientific, panel, and executive sessions. Governmental strategies and regulatory support. KAIMRC and the Ministry of Investment launched BioSync. The one stop shop for every biotech investor, consolidating the Kingdom's entire life sciences ecosystem into a single, authoritative platform. Regulators and scientists shared the stage throughout the program, culminating in a Day Three panel on regulation as an enabling scientific tool. Investment and funding. Vaccine Industrial Company confirmed that its human vaccine manufacturing facility, a SAR 500 million investment across 42,000 square meters, is 85 percent complete and is planned to localize up to 80 percent of the Kingdom's essential vaccine needs. Sanabil Studio by Redesign Health signed with Telepath by Tahlili on AI and digital pathology, with a potential investment of USD 3 million, and the Life Sciences Innovation Forum drew applications from more than 100 companies, nominated more than 25 for investment, and engaged five investment funds willing to invest with a combined value of more than USD 120 million. Research and development readiness. King Abdullah International Medical Research Center (KAIMRC) and Thermo Fisher Scientific announced a Center of Excellence for Genomics, Proteomics, and Biobanking. The University Hospitals Program at the Council of Universities' Affairs signed with Novo Nordisk to build clinical trial capability, including earlier phase trials. KAIMRC also agreed research collaborations with Olink in proteomics, Tiziana Life Sciences in immunomodulation and neuroimmunology, and Japan's Chiyoda Corporation in plant-based peptide production for cancer treatment. King Saud University and BioMe of South Korea signed to establish a microbiome joint venture, the University of Hafr Al Batin partnered with BGI Group, and Najran University launched the Najran Genomic Biobank Initiative. Building capabilities. KAIMRC signed with Rutgers University on a summer school, master's programs, and research in artificial intelligence, and with LeapUp on training and capacity building. Princess Nourah bint Abdulrahman University and Cellenkos launched a program to develop Saudi female talent in cell and gene therapy and biomanufacturing, and SVAX and Batterjee Medical College agreed accredited biomanufacturing training with up to 350 seats per cycle. King Saud University launched four national initiatives, including an annual Saudi International Biotechnology Conference and the KSU BioHack hackathon. THREE DAYS ON THE MAIN STAGE Day One: The program opened with the National Biotechnology Strategy and a session on global partnership with Dr. Steve Yang of WuXi AppTec, Mr. Alec Reynolds of Flagship Pioneering, and Prof. Ahmed Alaskar of KAIMRC, before turning to AI in biotechnology and multi-omics, including Prof. Jin-Soo Kim of KAIST on mitochondrial DNA editing beyond CRISPR. Day Two: Investment, immunology, and bioengineering took the stage, with Mr. Kasim Kutay of Novo Holdings on investing in AI, Prof. Keith T. Flaherty, President of the American Association for Cancer Research, on cancer immunology, Astronaut Rayyanah Barnawi on the human immune system in space, and Dr. Matthew H. Porteus of Stanford University on CRISPR-engineered cell-based drugs. Day Three: The final day focused on the biotechnology workforce and regulation, a closing keynote from Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, ahead of the closing ceremony. "RGMBS 2026 has shown the world what Saudi Arabia means when it says biotechnology is a national mission. We named this edition for foundations, and over three days those foundations were laid in full view: a vaccine plant nearing completion, a genomics center with Thermo Fisher, clinical trials with Novo Nordisk, and training for a new generation of Saudi scientists, each with a named partner and a defined scope. "Under the direction of our leadership and the National Biotechnology Strategy, the Kingdom is committed to leading this field for decades to come. We will measure that leadership by one standard above all: the difference it makes to the lives of patients and their families." H.E Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of KSAU-HS and KAIMRC Chairman of RGMBS . RGMBS 2026 was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC), with the Ministry of Investment, Invest Saudi, and the FII Institute serving as strategic partners. The commitments made in Riyadh advance the National Biotechnology Strategy, which targets a USD 34.6 billion contribution to non-oil GDP from biotechnology by 2040, and confirm the Kingdom's place at the forefront of global biotechnology in the years ahead. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: [email protected] Telephone: +966 559 810 777
- RGMBS 2026 Life Sciences Innovation Forum Draws More Than USD 120 Million in Investor Interest as 23 Global Biotech Innovators Pitch in RiyadhRIYADH, KSA, Sept 18, 2026 - The Life Sciences Innovation Forum (LSIF), the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), brought 23 biotechnology companies from eight countries to Riyadh to pitch to investors, judges, and leaders of the Kingdom's life sciences ecosystem. Companies from eight countries pitched to investors across five scientific heats, with Saudi Arabia the second-largest market represented. Dr Abdulaziz Alrifi, Director Of Partnerships, KAIMRC, stated, "We were proud to welcome leading investment firms that expressed their willingness to invest more than $USD 120 milliond in promising biotech opportunities emerging from LSIF 2026. The journey culminated with the announcement of the LSIF 2026 Grand Winner: Bilix from South Korea." On winning, a representative of Bilix enthused, "Winning LSIF 2026 is a great honor, however the real win is scaling our startup with the Kingdom's research ecosystem" Where RGMBS 2026 set out the scale of Saudi Arabia's biotechnology ambition, LSIF put that ambition in front of the founders and investors who will shape the sector's next decade. The United States led the cohort with eight companies, with Saudi Arabia second at four, followed by South Korea, the United Kingdom, Australia, France, Germany, and Switzerland. Several international companies presented pathways to localization, research, or clinical development in the Kingdom. FIVE HEATS, ONE FRONTIER Companies competed across five heats, each at the leading edge of life sciences innovation. AI and Bio Data. Amprologix of the United Kingdom presented AI-assisted discovery of narrow-spectrum peptide antibiotics targeting drug-resistant pathogens. Pneumatica Bio of Australia combines mechanistic modelling, machine learning, and automated cell experiments to better predict human therapeutic response, while Saudi company LinusBio MENA presented precision exposomics built on hair-based biomarker profiling. Vaccine Development and Biomanufacturing. Biotech Innovations Company of Saudi Arabia presented a recombinant-protein MERS-CoV vaccine program focused on regional biosecurity and local manufacturing. OctoCells of France presented an animal-free 3D bioscaffold platform designed to reduce the water, infrastructure, and manufacturing burden of producing biologics and cell therapies, and Cevza Therapeutics of Australia an RNA therapy platform with planned research and development localization in the Kingdom. Cellular Therapy and Gene Editing. CellKure of the United States highlighted Phase 1 results for its multi-antigen T-cell therapy in acute myeloid leukemia. MVRIX of South Korea presented an in vivo CAR-T approach using targeted mRNA delivery, and Saudi company Medixcel a platform to bring cell and gene therapy capabilities, partnerships, and manufacturing into the Kingdom. Bioengineering and Synthetic Biology. NanoZymeX of Switzerland presented a lipid nanoparticle platform to improve enzyme replacement therapy for lysosomal storage diseases, beginning with Pompe disease. AUREXO Therapeutics of the United States presented engineered bacterial vesicles for precision oncology, and Ingenskin Therapeutics of France an autologous skin substitute for chronic wounds, burns, and trauma. Diagnostics and Drug Discovery. SiNON Nano Sciences of the United States presented a carbon nanoparticle platform designed to cross the blood-brain barrier. Spirea of the United Kingdom presented a dual-payload antibody-drug conjugate platform to address cancer drug resistance, and Accanito Therapeutics of the United States a clinical-stage oncology platform with a proposal for technology transfer and local manufacturing in Saudi Arabia. Questions from judges and the audience concentrated on turning science into treatments: regulatory routes, clinical evidence, manufacturing scale-up, localization economics, and intellectual property. LSIF 2026 was sponsored by Chiyoda Corporation. Alongside Grand Winner Bilix, four category awards were presented: the Most Scalable Biotech Startup Award to CellKure, the Outstanding Founding Team Award to Quantabia, the Breakthrough Science Award to Swaza, and the Innovation Excellence Award to Agemica. LSIF 2026 took place as part of RGMBS 2026, held from 14 to 16 September in Riyadh. The Summit was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment, Invest Saudi, and the Saudi Data & AI Authority (SDAIA) serving as key strategic partners. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: [email protected] Telephone: +966 559 810 777
- AceMyHomeworkAceMyHomework Expands Personalized Academic Support After Serving 10,000+ Students Across 50+ SubjectsAceMyHomework is expanding personalized academic support after serving more than 10,000 students since 2019. The platform connects students with more than 500 verified subject experts and provides 24/7 online homework help across more than 50 subjects. As learning becomes more digital,...
- The Robert Irvine FoundationPerformance Drone Works Serves as Title Sponsor of Robert Irvine Foundation's Red Wine & Blues Event in ArlingtonThe Robert Irvine Foundation hosted its fifth annual Red Wine & Blues on September 15, 2026, bringing together senior military leaders from every branch at the Army Navy Country Club. Guests enjoyed a four-course menu designed by Chef Robert...
- Mission TelecomMission Telecom Joins TIPS Vendor List, Simplifying Access to Affordable BroadbandThis addition streamlines procurement and shortens timelines for schools, higher education, libraries, public sector entities, and nonprofits seeking affordable, reliable broadband — Mission Telecom, a nonprofit telecommunications provider...
- NuventiveNuventive Builds Momentum Across California Community Colleges as More Institutions Invest in Evidence-Based Improvement12 California community colleges expand Nuventive's presence in the US' largest higher education system — Nuventive is building significant momentum across California as community colleges increasingly look for stronger ways to manage institutional...
- National UniversityFormer Army Secretary, Military Family and Veterans Leaders, and University Presidents to Spotlight Tuition Assistance Modernization on Capitol HillBriefing will examine proposed FY 2027 NDAA updates to the Department of Defense program and their impact on today's service members — On Tuesday, September 22, National University will host a Capitol Hill policy briefing on the future of the U.S....
- Comprehensive Dental CareComprehensive Dental Care Launches New Website and Welcomes Dr. Gosia Fryc in West HartfordWest Hartford dental practice introduces a redesigned online home and adds a University of Connecticut graduate to its team of dentists. — Comprehensive Dental Care has launched a newly redesigned website for its